Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money
Choose your broker below
Welcome to ETFdb.com. Please help us personalize your experience.
Select the one that best describes you

GDNA
Goldman Sachs Human Evolution ETF

Price: $68.46
Change: $0.19 (0.0%)
Category: Health & Biotech Equities
Last Updated:

Vitals

Investment Themes

Trading Data

Open - Volume -
Day Lo - Day Hi -
  • Open
  • Volume
  • Day Lo
  • Day Hi
  • 52 Week Lo $41.45
  • 52 Week Hi $68.60
  • AUM $63.3 M
  • Shares 1.0 M

Analyst Report

Given the name, investors considering the Goldman Sachs Human Evolution ETF (GDNA) can be forgiven for wondering if the portfolio includes Cyberdyne Systems, Incite Inc., and Delos. (Dystopian pop-culture references to fictional companies in the Terminator movies and HBO’s Westworld series.) It doesn’t. GNDA invests largely in health and biotechnology stocks, tracking a bespoke index that tries to provide “exposure to the beneficiaries of technological innovation, regardless of sector, geography or market capitalization.” The investments are selected and weighted “by a function of ‘thematic’ beta.’” Top holdings include Intuitive Surgical Inc., Abbott Laboratories, Medtronic, and Johnson & Johnson.

GDNA’s management fee is high compared to ultra-low-cost plain-vanilla index funds, but it isn’t outrageous for smart-beta funds or niche products. One plain-vanilla index option is the iShares Genomics Immunology and Healthcare ETF (IDNA), which isn’t much cheaper than GDNA. For investors who want access to the sector and don’t mind paying a bit extra, there’s also actively-managed ETFs such as the ARK Genomic Revolution ETF (ARKG). Run by the stock-picking team at ARK Invest, ARKG absolutely trounced GDNA’s performance in the first five months of 2020, a tumultuous period marked by pandemic shutdowns and social unrest.

GDNA is one of five ETFs that Goldman launched in 2019 with indexes designed by Motif Investing Inc. The indexes selected stocks using artificial intelligence and machine learning. Goldman worked with Motif to design indexes that aim to identify companies that fit with broad themes that Goldman’s money managers thought would drive growth. (The “Motif” moniker was removed from the fund name in May 2020 when Motif dropped out as the index provider.) The funds were yet another example of Wall Street’s increased use of sophisticated automation. Computers read faster than human analysts, quickly scouring regulatory filings, company reports and news stories for information on a company’s prospects. Using AI and machine learning isn’t that much of a divergence — after all, most factor funds and smart-beta ETFs are really just attempts to codify investing strategies employed by human stock pickers. Whether it’s a plain-vanilla index or something more sophisticated, index methodology is basically just programmed code that tells the index what to buy and sell.

Historical Trading Data

  • 1 Month Avg. Volume 3,414
  • 3 Month Avg. Volume 5,745

Alternative ETFs in the Health & Biotech Equities Category

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FHLC 0.08% $2.6 B 209,066 3.83%
Largest (AUM) XLV 0.13% $26.0 B 8 M 3.11%
Most Liquid (Volume) XLV 0.13% $26.0 B 8 M 3.11%
Top YTD Performer MJJ 0.70% $46.8 M 1,173 20.79%

Top 15 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.

506
Number of Holdings
16.87%
% Assets in Top 10
21.52%
% Assets in Top 15
40.42%
% Assets in Top 50
 
View Detailed Analysis
 
Number of Holdings
506
Rank
1 of 43
Low
IXJ (2)
High
GDNA (506)
% Assets in Top 10
16.87%
Rank
4 of 43
Low
BBC (10.64%)
High
IXJ (100.00%)
% Assets in Top 15
21.52%
Rank
41 of 43
Low
BBC (14.50%)
High
IXJ (100.00%)
% Assets in Top 50
40.42%
Rank
42 of 43
Low
BBC (38.14%)
High
BBH (100.02%)

 
View Summary Analysis
 

Sector Breakdown

Asset Percentage
Common equity 99.91%
ETF Cash Component 0.09%
Sector Percentage
Healthcare 88.82%
Other 11.09%
ETF Cash Component 0.09%
Market Cap Percentage
Large cap 57.35%
Mid cap 17.31%
Small cap 14.49%
Micro cap 10.76%
ETF Cash Component 0.09%
Region Percentage
North America 70.66%
Europe 20.78%
Asia 5.28%
Asia-Pacific 2.45%
Middle East 0.74%
ETF Cash Component 0.09%
Region Percentage
United States 70.66%
Developed Markets (ex-US) 23.96%
Emerging Markets 5.28%
ETF Cash Component 0.09%
Country Percentage
United States 70.66%
Germany 7.41%
Switzerland 5.49%
China 5.28%
United Kingdom 4.66%
France 2.26%
Japan 1.55%
Netherlands 0.96%
Israel 0.74%
Australia 0.5%
Hong Kong 0.4%
ETF Cash Component 0.09%
 
View Less Charts
 
Asset Percentage
Common equity 99.91%
ETF Cash Component 0.09%
 
View More Charts
 

GDNA Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb.com Category.

P/E Ratio
32.92
Rank
28 of 35
Low
PTH (-485.52)
High
EDOC (74.67)

GDNA Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb.com Category.

Dividend
$0.18
Dividend Date
2020-10-29
Annual Dividend Rate
$0.39

$0.18
Dividend
2020-10-29
Dividend Date
$0.39
Annual Dividend Rate
Annual Dividend Yield
0.57%
Rank
16 of 33
Low
KMED (0.02%)
High
IEIH (2.71%)

GDNA Fund Flows

View charts featuring ETF fund flow data.

5 Day Net Flows: -49.83 M 1 Month Net Flows: -93 K 3 Month Net Flows: 14.26 M 6 Month Net Flows: 34.49 M 1 Year Net Flows: 46.69 M 3 Year Net Flows: 50.5 M 5 Year Net Flows: 50.5 M 10 Year Net Flows: 50.5 M

Realtime Rating

The adjacent table gives investors an individual Realtime Rating for GDNA on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Sign Up for Pro to Unlock Data Sign Up
Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity n/a n/a
Expenses n/a n/a
Performance
Volatility
Dividend
Concentration

A+ Overall Rated ETF:

GDNA Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb.com Category.

Expenses Ratio Analysis

ETF Average
0.537%
ETF Wtd. Average
0.19%
Category Average
0.48%
Expense Ratio
0.50%
Rank
25 of 42
Low
FHLC (0.08%)
High
KMED (0.79%)
ESG Themes and Scores
5.57/10
ESG Score
41.55%
Global Percentile
31.65%
Peer Percentile
Environmental
Social
Governance
  • Environmental Scores
    • Revenue Exposure to Environmental Impact (%)
      Higher is better, no ESG score impact
    • Severe Environment Controversies (%)
      Lower improves ESG score
    • Sustainable Impact Solutions (%)
      12.2%
      Higher is better, no ESG score impact
    Carbon Intensity
    • Weighted Average Carbon Intensity (Tons of CO2e / $M Sales)
      23.34
      Higher is worse, no ESG score impact
    Fossil Fuel Reserves
    • Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    • High Impact Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    Water Stress
    • Water Stress High Risk Business Segment (%)
      Lower improves ESG score
    • Water Stress High Risk Geography (%)
      Lower improves ESG score
    • Water Stress Exposure Moderate (%)
      Lower improves ESG score
    • Water Stress Exposure High (%)
      Lower improves ESG score
    • Water Stress Exposure Low (%)
      Higher improves ESG score
    Energy Efficiency
    • Revenue Exposure to Energy Efficiency (%)
      Higher is better, no ESG score impact
    Alternative Energy
    • Revenue Exposure to Alternative Energy (%)
      Higher is better, no ESG score impact
    Green Building
    • Revenue Exposure to Green Building (%)
      Higher is better, no ESG score impact
    Pollution Prevention
    • Revenue Exposure to Pollution Prevention (%)
      Higher is better, no ESG score impact
    Water Sustainability
    • Revenue Exposure to Water Sustainability (%)
      Higher is better, no ESG score impact
  • Social Scores
    • Revenue Exposure to Social Impact (%)
      Higher is better, no ESG score impact
    • Sustainable Impact Solutions (%)
      12.2%
      Higher is better, no ESG score impact
    • SRI Exclusion Criteria (%)
      0.0%
      Higher is worse, no ESG score impact
    Affordable Real Estate
    • Revenue Exposure to Affordable Real Estate (%)
      Higher is better, no ESG score impact
    Education
    • Revenue Exposure to Education (%)
      Higher is better, no ESG score impact
    Major Disease Treatment
    • Revenue Exposure to Major Disease Treatment (%)
      Higher is better, no ESG score impact
    Healthy Nutrition
    • Revenue Exposure to Nutrition (%)
      Higher is better, no ESG score impact
    Global Sanitation
    • Revenue Exposure to Sanitation (%)
      Higher is better, no ESG score impact
    SME Finance
    • Revenue Exposure to SME Finance (%)
      Higher is better, no ESG score impact
    Human Rights Violations
    • Human Rights Norms Violation (%)
      Higher is worse, no ESG score impact
    • Human Rights Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Human Rights Controversies (%)
      Lower improves ESG score
    Labor Rights Violations
    • Labor Norms Violation (%)
      Higher is worse, no ESG score impact
    • Labor Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Labor Controversies (%)
      Lower improves ESG score
    Customer Controversies
    • Severe Customer Controversies (%)
      Lower improves ESG score
    UN Principles Violations
    • Global Compact Compliance Violation (%)
      Higher is worse, no ESG score impact
    • Global Compact Compliance Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    Catholic Values
    • Catholic Values Fail (%)
      Higher is worse, no ESG score impact
    Sharia Compliant Investing
    • Islamic Non-Compliant (%)
      Higher is worse, no ESG score impact
    Adult Entertainment
    • Adult Entertainment Involvement (%)
      Higher is worse, no ESG score impact
    Alcohol
    • Alcohol Involvement (%)
      Higher is worse, no ESG score impact
    Gambling
    • Gambling Involvement (%)
      Higher is worse, no ESG score impact
    Nuclear Power
    • Nuclear Power Involvement (%)
      Higher is worse, no ESG score impact
    Tobacco
    • Tobacco Involvement (%)
      Higher is worse, no ESG score impact
    Weapons Involvement
    • Weapons Involvement (%)
      Higher is worse, no ESG score impact
    • Controversies Weapons Involvement (%)
      Higher is worse, no ESG score impact
    Firearms
    • Civilian Firearms Involvement (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Retailer (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Producer (%)
      Higher is worse, no ESG score impact
    Predatory Lending
    • Direct Predatory Lending Involvement (%)
      Higher is worse, no ESG score impact
    GMO Involvement
    • Genetic Engineering Involvement (%)
      Higher is worse, no ESG score impact
  • Responsible Governance Score
    • Severe Governance Controversies (%)
      Lower improves ESG score
    Board Flag
    • Board Flag (%)
      Lower improves ESG score
    Board Independence
    • Lack of Independent Board Majority (%)
      Lower improves ESG score
    • Board Independence (0-25%) (%)
      Lower improves ESG score
    • Board Independence (25-50%) (%)
      Lower improves ESG score
    • Board Independence (50-75%) (%)
      Higher improves ESG score
    • Board Independence (75-100%) (%)
      Higher improves ESG score
    Board Diversity
    • No Female Directors (%)
      Lower improves ESG score
    • Three OR More Female Directors (%)
      Higher improves ESG score
    • Females Represent 30% of Directors (%)
      Higher improves ESG score
    Entrenched Board
    • Entrenched Board (%)
      Lower improves ESG score
    Overboarding
    • Overboarding (%)
      Lower improves ESG score
    Shareholder Rights
    • Negative Director Votes (%)
      Lower improves ESG score
    • Ownership AND Control Flag (%)
      Lower improves ESG score
    • One Share One Vote (%)
      Lower improves ESG score
    • No Annual Director Elections (%)
      Lower improves ESG score
    • Does Not Use Majority Voting (%)
      Lower improves ESG score
    • Significant Votes Against Pay Practices (%)
      Lower improves ESG score
    Fund Ownership
    • Controlling Shareholder (%)
      Lower improves ESG score
    • Controlling Shareholder Concerns (%)
      Lower improves ESG score
    • Cross Shareholdings (%)
      Lower improves ESG score
    Poison Pill
    • Poison Pill (%)
      Lower improves ESG score
    Executive Compensation
    • Pay Flag (%)
      Lower improves ESG score
    • No Pay Performance Link (%)
      Lower improves ESG score
    • Lack of Internal Pay Equity (%)
      Lower improves ESG score
    • Executive Pay Non-Disclosure (%)
      Lower improves ESG score
    Accounting Flags
    • Accounting Flag (%)
      Lower improves ESG score

GDNA Performance

This section shows how this ETF has performed relative to its peer group ETFdb.com Category.

8.94%
1 Week Return
1.59%
4 Week Return
7.17%
13 Week Return
19.88%
26 Week Return
22.32%
Year to Date Return
33.25%
1 Year Return
No Ranking Available
3 Year Return
No Ranking Available
5 Year Return
 
View Detailed Analysis
 
1 Week Return
8.94%
Rank
2 of 43
Low
KMED (-2.68%)
High
MJJ (9.21%)
4 Week Return
1.59%
Rank
43 of 43
Low
GDNA (1.59%)
High
MJJ (19.54%)
13 Week Return
7.17%
Rank
42 of 43
Low
IHI (6.42%)
High
ARKG (47.67%)
26 Week Return
19.88%
Rank
19 of 41
Low
FBT (-0.41%)
High
ARKG (90.41%)
Year to Date Return
22.32%
Rank
1 of 43
Low
KMED (0.26%)
High
GDNA (22.32%)
1 Year Return
33.25%
Rank
15 of 40
Low
PPH (6.33%)
High
ARKG (204.59%)
3 Year Return
No Ranking Available
Rank
N/A
Low
PJP (15.19%)
High
ARKG (354.82%)
5 Year Return
No Ranking Available
Rank
N/A
Low
XPH (23.30%)
High
ARKG (561.10%)

 
View Summary Analysis
 

GDNA Price and Volume Chart

GDNA Technicals

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.

 
View Detailed Analysis
 
5 Day Volatility
25.64%
Rank
38 of 43
Low
EDOC (8.21%)
High
RYH (207.60%)
20 Day Volatility
24.90%
Rank
11 of 43
Low
IXJ (7.77%)
High
ARKG (50.79%)
50 Day Volatility
24.82%
Rank
13 of 43
Low
IEHS (13.16%)
High
ARKG (46.50%)
200 Day Volatility
22.45%
Rank
18 of 43
Low
IXJ (15.51%)
High
ARKG (44.54%)
Beta
0.82
Rank
37 of 43
Low
KMED (0.69)
High
HELX (2.57)
Standard Deviation
5.67%
Rank
25 of 40
Low
FTXH (1.96%)
High
IHI (31.44%)

 
View Summary Analysis
 

Technicals

  • 20 Day MA $66.27
  • 60 Day MA $64.71
  • MACD 15 Period 2.62
  • MACD 100 Period 4.80
  • Williams % Range 10 Day 1.83
  • Williams % Range 20 Day 2.24
  • RSI 10 Day 65
  • RSI 20 Day 60
  • RSI 30 Day 58
  • Ultimate Oscillator 63

Bollinger Brands

  • Lower Bollinger (10 Day) $62.20
  • Upper Bollinger (10 Day) $68.94
  • Lower Bollinger (20 Day) $63.33
  • Upper Bollinger (20 Day) $69.31
  • Lower Bollinger (30 Day) $62.51
  • Upper Bollinger (30 Day) $69.03

Support & Resistance

  • Support Level 1 $68.02
  • Support Level 2 $67.59
  • Resistance Level 1 $68.73
  • Resistance Level 2 $69.01

Stochastic

  • Stochastic Oscillator %D (1 Day) 72.61
  • Stochastic Oscillator %D (5 Day) 81.50
  • Stochastic Oscillator %K (1 Day) 57.15
  • Stochastic Oscillator %K (5 Day) 61.80

Fact Sheet

A fact sheet is not available for this ETF. Please visit the GDNA ETF home page for more information.

Disclosures

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at https://www.msci.com/esg-fund-metrics.
© 2021 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.
Help & Info
Tools
More Tools
Explore ETFs
Legal